Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: rocuronium

August 18, 2025 CD as API / CD derivatives / Pharma applications

Results of Phase III clinical trial on efficacy and safety of Adamgammadex

This multicentre, randomised, double-blind, positive-controlled, noninferiority phase III clinical trial aimed to investigate the efficacy and safety of adamagammadex compared

Continue reading

July 26, 2022 CD as API / Pharma applications

Novel Case Study with Sugammadex in Pregnant Women

The use of sugammadex (SGM) after caesarean section is nowadays common practice, but there haven’t been reported any case studies

Continue reading

September 28, 2021 CD as API / Pharma applications

Comparison of Selective Relaxant Binding Agent Adamgammadex Sodium with Sugammadex for Reversing Rocuronium-Induced Deep Neuromuscular Block

Zhao et al. reported on a phase IIa, single-center, randomized, open-label, and dose-finding study that enrolled 35 patients under general

Continue reading

August 24, 2021 CD as API / Pharma applications

Carboxymethyl-γ-cyclodextrin, a novel selective relaxant binding agent for the reversal of neuromuscular block induced by aminosteroid neuromuscular blockers: an ex vivo laboratory study

Residual neuromuscular block at the end of surgery may compromise the patient’s safety. The risk of airway complications can be

Continue reading

Recent Posts

  • HPBCD-enhanced Vaginal Hydrogel: Innovative Treatment for Menopause Symptoms
  • Association of Sugammadex Exposure with Venous Thrombosis Risk Following Primary Total Knee Arthroplasty: A Multi-Institutional Retrospective Analysis
  • Special Issue titled “Cyclodextrins: Properties and Applications, 4th Edition”
  • Cyclodextrins hit the golf course seven years ago — and they are still there
  • Enhancing Curcumin Efficacy Against Triple-Negative Breast Cancer

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (73)
  • CD as API (356)
  • CD derivatives (431)
  • Cosmetics and toilettry (54)
  • Diagnosis (15)
  • Drug delivery (817)
  • E-ducation (63)
  • Environmental (143)
  • Events (239)
  • Food (233)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (45)
  • Non-pharma applications (416)
  • Other industrial use (112)
  • Pharma applications (1,221)
  • Supramolecular systems (44)
  • Uncategorized (167)

Top Posts

  • Association of Sugammadex Exposure with Venous Thrombosis Risk Following Primary Total Knee Arthroplasty: A Multi-Institutional Retrospective Analysis
  • HPBCD-enhanced Vaginal Hydrogel: Innovative Treatment for Menopause Symptoms
  • Phosphorylated Beta-cyclodextrin as a New Bone-Targeting Drug Delivery System Could Change the Treatment of Osteoporosis and Other Bone Diseases
  • MANU-KAMU - Dog dental treats with cyclodextrin
  • Reducing Cholesterol with β-CDP: Insights for NPC and AD
  • Cyclodextrins hit the golf course seven years ago — and they are still there
  • Beyond Cholesterol: New Review Examines 7-Ketocholesterol and Its Role in Disease
  • Synthesis and potential applications of cyclodextrin-based metal–organic frameworks: a review
  • Piroxicam/Cyclodextrin: 35 years on the market
  • Meow! In Japan cyclodextrins are taking cat products to the next level! 😺

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,476 other subscribers
Loading Comments...